HOME >> MEDICINE >> NEWS
Chemists Closing In On Commercial Potential Of Alkanes

BERKELEY, CA -- The elusive goal of harnessing the vast potential of one of the earth's most plentiful materials is another step closer to realization. Using ultrafast spectroscopic techniques that provide "stop-action" images within a trillionth of a second, scientists at the U.S. Deparment of Energy's Lawrence Berkeley National Laboratory have obtained the first detailed picture of an alkane-activation reaction at room temperature.

Alkanes are compounds of carbon and hydrogen atoms held together by single bonds. The simplest and most abundant is methane, the primary constituent of natural gas. Chemists have long coveted the use of alkanes as environmentally benign feedstock for clean-burning fuels and a host of petrochemicals, including plastics, solvents, synthetic fibers, and pharmaceutical drugs. The problem has been that the bonds between an alkane's carbon and hydrogen atoms are strong enough to render alkanes generally unreactive.

In the early 1980s, Robert Bergman, a chemist in Berkeley Lab's Chemical Sciences Division (CSD) and with the University of California at Berkeley, led the discovery of a group of organometallic complexes --compounds of metal atoms, such as iridium or rhodium, sandwiched between organic molecules with a unique property. Upon irradiation with ultraviolet light, these organometallics were shown to generate a reaction that is able to break the carbon-hydrogen bonds in alkanes and insert metal atoms into the mix, creating new, much more reactive carbon-metal-hydrogen compounds.

Since discovering this alkane-activating reaction, Bergman has been working to better understand it with the ultimate aim of designing a catalytic process that could be used in commercial operations. An obstacle has been that the reaction takes place within 230 nanoseconds (billionths of a second). To slow it down for detailed study, Bergman and Bradley Moore, another chemist who also holds a joint Berkeley Lab-UC Berkeley ap
'"/>

Contact: Lynn Yarris
lcyarris@lbl.gov
510-486-5375
DOE/Lawrence Berkeley National Laboratory
2-Feb-1998


Page: 1 2 3

Related medicine news :

1. Chemists identify immune system mechanism for methamphetamine binges
2. Chemists synthesize molecule that helps body battle cancers, malaria
3. Chemists honor Heroes for biotechnology achievements in health
4. Chemists seek light-activated glue for vascular repair
5. Chemists create synthetic cytochromes
6. Chemists show proteins behave differently inside cells than they do in water solutions
7. Chemists take new approach to fighting resistance
8. Chemists Discover That Aerosol Clusters Play Larger Role In Generation Of Air Pollution
9. Over 6,000 Technical Presentations Will Reveal New Findings At National Chemists Meeting In Boston, August 23 - 27
10. Chemists Develop Probe To Detect Changes In Imaging Agents Inside Body
11. Commercial driving not linked to permanent back injury

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Chemists Closing Commercial Potential Alkanes

(Date:5/22/2013)... Successful Therapy for Parents program, ... in the Silver Lake community of Los Angeles ... progression to existing Parents and Couples counseling programs. ... therapy has always been suggested, but now it's ... specializes in all aspects of relationships ...
(Date:5/22/2013)... Rapids, IA (PRWEB) May 22, 2013 ... theatre piece Handicap This! The performance promotes awareness ... their dreams. The Handicap This! performance will be held ... Mar High School auditorium. Tickets for Handicap This! ... Handicap This! helps audiences measure the level to which ...
(Date:5/22/2013)... City, UT (PRWEB) May 22, 2013 ... the Alabama Health Insurance Exchange . Zane Benefits, ... sponsored health benefits, is the leader in defined ... , According to Zane Benefits’ website, beginning in 2014 ... insurance coverage for individuals and small businesses will become ...
(Date:5/22/2013)... Over the next two decades, the cost of treating ... than double, topping more than $180 billion a year, ... the increase: an aging population. The report, from the ... was published May 22 in the journal Stroke ... system," Dr. Bruce Ovbiagele, chairman of the department of ...
(Date:5/22/2013)... Award Presented at the 2013 Annual M&A ... http://bit.ly/13DkFfk , Merrill Corporation is pleased to ... of the Year” at the 7th M&A Advisor Turnaround ... in Palm Beach, Florida. , Merrill DataSite is ... solution that optimizes the due diligence process and offers ...
Breaking Medicine News(10 mins):Health News:Patricia O’Laughlin Psychotherapy of Los Angeles Now Seeing Adults, Teens and Young Children 2Health News:Handicap This! Comes to Marion, Iowa 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 3Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 3Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 2Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 3
(Date:5/22/2013)...  The Leukemia & Lymphoma Society (LLS) is committing ... a joint venture between ImmunGene and Caliber, to co-fund ... I clinical trial for a novel fusion protein that ... with indolent lymphomas who do not respond to standard ... is a new class of biotherapeutics produced by fusing ...
(Date:5/22/2013)... 22, 2013 The new 13-valent pneumococcal conjugate ... previous version used prior to 2010, the 7-valent pneumococcal ... published today in Vaccine. The U.S. Food ... 2010 after a series of trials. These trials found ... pneumococcal types than the previously used PCV7, did not ...
(Date:5/22/2013)... NEW YORK , May 22, 2013 ... Gross LLP is investigating claims on behalf of investors ... (NASDAQ: ISRG ) (CUSIP: 46120E602) who purchased ... April 18, 2013 (the "Class Period"). Such investors are ... at rswilloughby@pomlaw.com or 888-476-6529, ext. 237. ...
Breaking Medicine Technology:The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 2Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 3Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 4SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG 2
Cached News: